A female clinician helps a male patient learn how to operate their new Medtronic insulin pump.

Those who purchased a MiniMedTM 670G system after 11/7/19 were automatically entered into the Next Tech Pathway program. This program allows your patients to access the MiniMedTM 770G system for $0. The order must be placed no later than September 1, 2021. See program terms and conditions for full details.


Instruct your patients to:

  1. Sign in to their account
  2. Under Devices and Products, select the “Check upgrade eligibility” button

Or your patient may also call 877-585-0208. Specialists are available from 8AM-6PM CT.

Diabetes.Shop Devices and Product web page.



The MiniMedTM 770G insulin pump system automatically adjusts insulin levels, adapts to your patients' insulin needs,* and self-adjusts using SmartGuardTM tech.


If your patients are not enrolled in Next Tech Pathway, we have other programs available for those using an in-warranty pump. Learn more.


See below for questions your patients may ask regarding the Next Tech Pathway program.

Expand All

When can my patients redeem Next Tech Pathway to upgrade to a new pump?

During your patients' warranty period, with more than 6 months left, your patient will have a one-time opportunity to upgrade to the MiniMedTM 770G system for $0. See below for more details.  Terms & Conditions apply.

How do my patients redeem Next Tech Pathway and how much will it cost?

How often can my patients upgrade using the Next Tech Pathway program?

Will my patients' pump warranty reset after upgrading using the Next Tech Pathway program?

What if my patient does not return their old insulin pump within 90 days?

What happens if my patient is already on the latest MiniMed™ insulin pump system?


Refers to SmartGuardTM Auto Mode. Some user interaction required. 

Terms and Conditions

The Next Tech Pathway program (the “Program”) allows eligible, enrolled participants whose MiniMed 670G system order is shipped starting on 11/7/19 to be included. The last day to place an order is 12/1/20. This Program allows for an upgrade to our next MiniMed system at $0. Eligibility dates subject to change.

To be eligible for the Program, participants must purchase a MiniMed™ 670G system and meet one of the following requirements:

  • New to Medtronic insulin pump therapy
  • Upgrade from an out-of-warranty pump

This program is not available to customers on a rental program such as those enrolled in federal, state, or other government-funded healthcare program like Medicare, Medicare Advantage, Medicaid, Medigap, the Department of Defense (“DoD”) or TRICARE.

To upgrade through the Program, all participants must agree and are subject to these terms and conditions:

  • Return of old MiniMed 670G insulin pump and transmitter is required. If the old pump and transmitter is not returned within 90 days, you will be charged $3,200.
  • Warranty period does not reset when you receive the new technology. The warranty period of an upgraded insulin pump and transmitter will remain the same as the warranty date of the initial pump and transmitter purchased.
  • MiniMed pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
  • Upon first commercial shipping of a new MiniMed system, it may take up to 90 days for Medtronic to contact you with the option to upgrade. Once you place your order, it may take up to 90 days to ship the new product. The Program does not guarantee prioritization of your order.
  • An upgrade through the Program can only be redeemed once during your warranty period for the next available technology and customers’ order no later than 9/1/21. The Program cannot be redeemed if less than six (6) months remains on your pump warranty.
  • The Program for the future upgrade applies to one (1) in-warranty insulin pump and one (1) in-warranty transmitter. CGM sensors and consumables are not included, however, these Medtronic products will remain compatible.
  • If transmitter is out of warranty, customer will need to purchase a new transmitter.
  • Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
  • A valid prescription will be required to purchase a new pump. All participants should consult their healthcare provider for all therapy related decisions.
  • Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.

Important Safety Information: MiniMedTM 770G System with SmartGuardTM Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at